Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 444,843	$ 595,082
Tax incentive receivable	19,961	15,392
Prepaid expenses and other current assets	12,186	18,300
Total current assets	476,990	628,774
Property and equipment, net	552	162
Other, net	1,813	699
Total assets	479,355	629,635
Current liabilities:
Accounts payable	10,858	8,065
Accrued expenses and other current liabilities	27,333	16,573
Total current liabilities	38,191	24,638
Long term debt	68,200	75,700
Contingent value rights	0	37,700
Other, net	43	43
Total liabilities	106,434	138,081
Commitments and contingencies (Note 6)
Shareholders’ equity:
Ordinary shares: £0.002 nominal value: 152,500,000 shares authorized, 94,571,651 issued and outstanding at September 30, 2022; 152,500,000 shares authorized, 89,988,228 issued and outstanding at December 31, 2021	263	252
Additional paid-in capital	933,040	876,267
Accumulated other comprehensive (loss) income	(1,695)	688
Accumulated deficit	(558,687)	(385,653)
Total shareholders' equity	372,921	491,554
Total liabilities and shareholders' equity	$ 479,355	$ 629,635